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Abstract 
Background Many Australians with arthritis self-manage their pain with prescription and/or over-the-
counter pain medications, containing paracetamol. If taken appropriately, these medications are relatively 
safe; however, if mismanaged through patients' inability to understand medication labels and instructions, 
these medications may cause adverse drug events and/or toxicities. Aim This study explored the 
prescription and over-the-counter pain medications most commonly used by people with arthritis and the 
ability of these patients to correctly identify paracetamol as an active ingredient in commonly available 
preparations. The study also investigated the functional health literacy of these patients and their 
inclination to borrow and/or share pain medications. Method Adult participants diagnosed with arthritis 
were invited to complete an anonymous survey which included questions about their prescription and 
over-the-counter pain medications; their medication borrowing and sharing behaviours; their functional 
health literacy; and their knowledge about preparations containing paracetamol as an active ingredient. 
Results Most of the 254 participants used analgesic agents containing paracetamol, as combination 
tablets (paracetamol 500 mg and codeine 30 mg) or paracetamol-only tablets (paracetamol 665 mg) to 
self-manage their pain. Respondents with low functional health literacy scores were significantly less 
likely to identify paracetamol as an active ingredient in both combination and paracetamol-only 
pharmaceutical products, and were more likely to guess or did not know how to identify that paracetamol 
was an active ingredient in these products. Almost 30% of the respondents indicated that they had and/or 
intended to borrow/share their over-the-counter pain medications whereas less than 10% suggested that 
they had and/or intended to borrow/share their prescription pain medication. Conclusion Australians with 
arthritis, especially those with low functional health literacy scores, self-managing their pain with 
paracetamol-containing products, do not always recognise paracetamol as an active ingredient in 
combination products, and may risk potential paracetamol-related adverse effects and/or toxicities. 
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Abstract 
Background 
Many Australians with arthritis self-manage their pain with prescription and/or over-the-
counter (OTC) pain medications, containing paracetamol. If taken appropriately, these 
medications are relatively safe; however if mismanaged through patients’ inability to 
understand medication labels and instructions, these medications may cause adverse drug 
events and/or toxicities.  
Aim 
This study explored the prescription and OTC pain medications most commonly used by 
people with arthritis and the ability of these patients to correctly identify paracetamol as an 
active ingredient in commonly available preparations. The study also investigated the 
functional health literacy of these patients and their inclination to borrow and/or share pain 
medications.  
Method 
Adult participants diagnosed with arthritis were invited to complete an anonymous survey 
which included questions about their prescription and OTC pain medications; their 
medication borrowing and sharing behaviours, their functional health literacy and their 
knowledge about preparations containing paracetamol as an active ingredient.   
Results 
Most of the 254 participants used analgesic agents containing paracetamol, as combination 
tablets (paracetamol 500mg and codeine 30mg) or paracetamol-only tablets (paracetamol 
665mg) to self-manage their pain. Respondents with low functional health literacy scores 
were significantly less likely to identify paracetamol as an active ingredient in both 
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combination and paracetamol-only pharmaceutical products, and we more likely to guess or 
didn’t know how to identify that paracetamol was an active ingredient in these products. 
Almost 30% of the respondents indicated that they had and/or intended to borrow/share their 
OTC pain medications whereas less than 10% suggested that they had and/or intended to 
borrow/share their prescription pain medication. 
Conclusion 
Australians with arthritis, especially those with low functional health literacy scores, self-
managing their pain with paracetamol-containing products do not always recognise 
paracetamol as an active ingredient in combination products, and may risk potential 
paracetamol-related adverse events and/or toxicities.  
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Introduction 
Arthritis is a widespread chronic health condition characterised by pain, joint inflammation, 
decreased mobility and discomfort [1] . According to a recent Australian National Health 
survey, over 3 million Australians are affected by some type of arthritis, the majority being 
aged 65 years and over [2]. Self-management of pain symptoms using analgesics is common; 
with paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) strongly represented 
in prescription-only and over-the-counter (OTC) pain medications [1, 3].  
High health literacy equips patients with the knowledge needed to find, interpret and 
understand health information [4], allowing them to achieve better health outcomes by 
making informed decisions [5-7]. Thus, people with arthritis who have high health literacy 
should be able to safely and effectively self-manage their pain medication because, in theory, 
they are effectively able to find, interpret and understand medication information and 
instructions. On the other hand, people with arthritis who have low health literacy may risk 
mismanaging their pain medications because, potentially, they are less likely to correctly 
identify and follow instructions. Evidence in the literature has identified that patients’ 
inability to identify the active ingredient in both prescription [8] and OTC medications [9] 
can lead to unintentional adverse events because of medication mismanagement. 
 
Previous studies have found that prescription pain medications are likely to be borrowed 
and/or shared more than any other kind of prescription medications[10-12]. This may be 
influenced by the availability of paracetamol and NSAIDs in various OTC preparations and 
their widespread acceptance as a convenient modality for managing pain [13, 14]. It is 
possible there is a perception that any pain medication containing those same ingredients, 
whether available on prescription, OTC, or both, is ‘safe’ to borrow or share. Unfortunately, 
however, borrowing and sharing behaviour can lead to adverse consequences [15], especially 
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among people already taking other medications, with undiagnosed sensitivities, or in those 
who have a chronic illness which contraindicates the use of these medications [16-18].  
 
The aim of this study was to identify the pain medication(s) most commonly used by people 
with arthritis and the ability of these patients to correctly identify paracetamol as an active 
ingredient in some commonly-used prescription and OTC pain medications. The study also 
investigated the functional health literacy levels of these people and whether or not they are 
inclined to borrow and/or share pain medications.  
Methods 
Following approval from the University of Wollongong Human Research Ethics committee 
(HE 11/314), a convenience sample of community-dwelling Australians with arthritis (aged 
over 18 years of age) was invited to take part in the study. A power calculation indicated a 
response of at least 220 participants was required. Participants diagnosed with arthritis were 
recruited between November 2011 and April 2012 from Illawarra-based community 
pharmacies, medical practices and residential aged-care facilities. They were also recruited 
by advertising the study via municipal council services, the local university of the Third Age 
group, the Arthritis NSW website and via social media (e.g. Facebook and Twitter). The first 
author was responsible for participant recruitment. She visited each of the aforementioned 
sites/organisations, and provided them with copies of the paper-based survey, together with 
stamped, self-addressed envelopes for the return of the completed surveys. Participants who 
preferred to submit their responses online were provided with a link to the survey. This link 
was also made available on the Arthritis NSW website and via the research team’s social 
media sites. The anonymous survey included questions pertaining to the respondent’s 
demographic information; which prescription and OTC pain medications they used, and how 
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often they used them; their medication borrowing and sharing behaviours (based on a 
modified version of the prescription medicine borrowing and sharing screening tool [19]); 
and their  functional health literacy scores, based on Ischikawa et al’s functional health 
literacy scale [20]. The functional health literacy scale [20] questions included: “In reading 
instructions or leaflets from hospitals/pharmacies about pain medicine, do you find: (a) the 
print is too small to read (b) there are words you don’t know (c) you need a long time to read 
and understand them (d) you need some-one to help you read them” The participants were 
asked to respond to these three questions by choosing one of the following responses: ‘never’ 
(score=4), ‘rarely’ (score =3), ‘sometimes’ (score =2) or ‘often’ (score =1). The scores for 
these questions were then summed and divided by four to determine the average functional 
health literacy score for each respondent. Respondents with average scores below 2 were 
deemed to have low functional health literacy, participants with scores between 2 and 3 were 
classified as having adequate functional health literacy and those with scores above 3 were 
classified as having high functional health literacy. In addition to these questions, the survey 
participants were asked to identify which of the different prescription and OTC preparations 
included in Figure 1 contain paracetamol as an active ingredient, and how they knew that 
these preparations contained paracetamol.  
There were no exclusion criteria for the study, other than a requirement for participants to be 
over 18 years of age and diagnosed with arthritis. However, only participants who were able 
to read the survey questions were able to complete the survey as there was no additional 
support provided. 
Analysis of the data included calculating frequencies for the number of participants taking 
pain medications, correctly identifying paracetamol as an active ingredient, their functional 
health literacy scores and their borrowing/sharing behaviours. Chi-square analyses were used 
to compare borrowing/sharing across high, adequate and low functional health literacy 
8 
 
groups. Differences in ability to correctly identify paracetamol containing medications as a 
function of their functional health literacy were assessed using multivariate analysis of 
variance. The IMB SPSS (Version 19) program was used to analyse the data. 
Figure 1: Survey question to determine participant knowledge of preparations containing paracetamol as 
an active ingredient 
 
 
 
Results 
Participant Information 
In total, 254 surveys were returned although not all questions were answered. The majority of 
the respondents were female (n = 181, 71.3%), aged 55 years and over (n = 169, 66.5%) and 
held either a trade certificate/diploma or at least a university degree (n = 153, 60.2%). Almost 
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three-quarters of the respondents (n = 184, 72.4%) had suffered from an arthritic condition 
for over five years.  
Based on the completed responses for the functional health literacy related questions from 
237 participants, the majority of them (n = 142; 59.9%) had adequate functional health 
literacy scores; just under a quarter of them (n = 55; 23.2%) had high functional health 
literacy scores and approximately one sixth of them (n = 40; 16.9%) had low functional 
health literacy scores.  
Prescription and OTC Pain Medications  
Prescription pain medications were taken by 185 (72.8%) participants. The most commonly 
prescribed pain medications were products containing paracetamol, in particular 500mg 
paracetamol in combination with codeine 30mg (i.e. Panadeine Forte™), and 665mg 
paracetamol-only (Panadol Osteo™) preparations (Table 1). Cyclo-oxygenase-2 (COX-2) 
inhibitors, opiates and NSAIDs were also prescribed for many of the study participants 
(Table 1). 
Table 1: Prescription Pain Medications taken by 185 of the 254 Study Participants: 
Prescription Pain Medication 
(Number & % of 185 participants taking prescription pain 
medications) 
Total Number of Prescription Pain 
Medications taken by Participants* 
(% of total prescription pain 
medications) 
Paracetamol-containing products 
 paracetamol 500mg/codeine 30mgs (n = 54, 29.2%) 
 paracetamol 665mg (n = 36, 19.5%) 
 paracetamol 500mg (n = 16 , 8.6%) 
 paracetamol 450mg/codeine 9.75mg-30mg/ doxylamine 
5mg (n = 6 , 3.2%) 
 paracetamol 325mg & dextropropoxyphene 32.5 mg (n = 3 
, 1.6%) 
115 (46.2%) 
Cox-2 inhibitors  
 meloxicam (n = 32 , 17.3%) 
 celecoxib (n = 22 , 11.9%) 
 etoricoxib (n = 1 , 0.5%) 
55 (22.1%) 
Opiates 
 tramadol (n = 27 , 14.6%) 
48 (19.3%) 
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 oxycodone (n = 16 , 8.6%) 
 morphine (n = 3 , 1.6%) 
 hydromorphine (n = 1 , 0.5%) 
 dextropoxyphene (n = 1 , 0.5%)   
NSAIDs  
 diclofenac (n = 15 , 8.1%) 
 ibuprofen (n = 2 , 1.1%) 
 ketoprofen (n = 3 , 1.6%) 
 naproxen (n = 7 , 3.8%) 
 piroxicam (n = 1 , 0.5%) 
28 (11.2%) 
Other  
 pregabalin (n = 1 , 0.5%) 
 gabapentin (n = 2 , 1.1%) 
3 (1.2%) 
Total Number of Prescribed Medications 249 (100%) 
*Note some of the participants reported that they were taking multiple prescription medications and 69 
participants did not list any prescription medications in their responses. 
 
Over-the-counter pain medications were taken by 195 (76.8%) participants, with the majority 
taking paracetamol-only (665mg or 500mg) preparations (Table 2). A smaller number of 
participants reported taking OTC NSAIDs and aspirin-containing preparations (Table 2).  
Table 2: OTC Pain Medications taken by 195 of the 254 Participants 
OTC Pain Medication 
(Number & % of 195 participants taking OTC pain medications) 
Total Number of OTC Pain 
Medications taken by Participants* 
(% of total OTCs medications) 
Paracetamol-containing products 
 paracetamol 665mg (n = 97, 49.7%) 
 paracetamol 500mg (n = 96, 49.2%%)  
 paracetamol 500mg/Codeine 8mg (n = 16 , 8.2%) 
 paracetamol 500mg/codeine 8mg (n = 16 , 8.2%) 
 paracetamol 450mg/codeine 9.75mg/doxylamine 5mg (n = 
6 , 3.1%) 
 
215 (87.4%) 
 
NSAIDs  
 diclofenac (n = 6 , 3.1%) 
 ibuprofen (n = 22 , 11.3%) 
 ibuprofen/codeine (n = 1 , 0.5%) 
29 (11.8%) 
Aspirin  
 aspirin (n = 2,1.0%)  
2 (0.8%) 
 
Total Number of OTC Pain Medications 246 (100%) 
*Note some of the participants listed that they were taking multiple OTC pain medications and 59 participants 
did not list any OTC medications in their responses. 
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Furthermore, 78 (30.7%) participants responded that they were taking at least two or more 
preparations containing paracetamol (as either prescription and/or OTC medications). An 
additional 13 (5.1%) participants responded that they were taking at least two or more COX-2 
inhibitors and/or NSAIDs combinations (as either prescription and/or OTC medications). 
 
Borrowing or Sharing of Pain Medications 
Just over 30% of the total participants (n = 71, 30.3%) indicated that they had 
borrowed/shared OTC pain medications within the last three months. However, less than 10% 
of the total participants (n = 22, 8.7%) indicated that they had engaged in the same behaviour 
with their prescription pain medications. While sharing of OTC pain medications was more 
common than sharing of prescription pain medications, there were no significant differences 
in sharing behaviour related to the functional health literacy of respondents i.e., those with 
low functional health literacy were equally as likely to have previously shared prescription 
and/or OTC pain medications as those with adequate and high functional health literacy ( 
(2, N = 234) = 2.708 p=0.258;  (2, N = 234) = 5.804, p = 0.055).  
Future intention to engage in borrowing/sharing behaviour was also examined. Similarly, a 
little under 30% of the total participants (n = 65, 27.5%) indicated that they would be ‘likely’ 
to borrow/share their OTC pain medications within the next three months while less than 
10% of the total participants (n = 19, 8.0%) indicated that they would be likely to engage in 
the same behaviour with their prescription pain medication. Once again, borrowing/sharing 
intentions did not differ as a function of their functional health literacy for either prescription 
or OTC pain medications ( (2, N = 234) = 1.306 p = 0.521;  (2, N = 234) = 2.708, p = 
0.258). 
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Knowledge of Paracetamol as an active ingredient in both Prescription and OTC 
Medications 
Knowledge about paracetamol as an active ingredient in both prescription and OTC 
medications varied among  the 229 responses (25 did not respond).  More than 80% of these 
respondents correctly identifying that the Herron Paracetamol™ (n = 187, 81.7%), Panadol 
Osteo™ (n = 196, 85.5%) and Panamax™ (n = 186, 81.2%) pharmaceutical brands 
contained paracetamol as an active ingredient (Figure 2). Between 60 and 70% of the 
respondents correctly identified that some combination pharmaceutical brands, such as 
Panadeine Forte™ (n = 154, 67.3%) and Panadol Flu Strength PE Day & Night™ (n = 151, 
65.9%) contained paracetamol, whereas fewer than 45% correctly identified that the 
Chemist’s Own Cold & Flu Relief™ (n = 96, 41.9%) and Mersyndol™ (n =  53, 23.1%) 
brands contained paracetamol as one of the active ingredients (Figure 2). Furthermore, the 
large majority of the respondents correctly identified that Aspro Clear™(n = 216, 94.3%), 
Disprin™(n = 221, 96.5%), Nurofen™ (n = 199, 86.9%)and OsteoEze™ (n = 179, 78.1%) 
did not contain paracetamol, while over 43% of the respondents incorrectly identified that 
Panafen Plus™ (n = 99, 43.2%) contained paracetamol as an active ingredient (Figure 2). 
Notably almost 10% of the participants (n = 25, 9.8%) did not respond to this question.  
Multivariate analysis of variance revealed a significant multivariate main effect of functional 
health literacy on paracetamol identification scores (Wilk's Lambda = .941, F(4, 466) = 
3.545, p = 0.007. Univariate ANOVAs indicated a non-significant effect of functional health 
literacy on mis-identification scores (F(2,234) = .891, p = .625) but a significant effect for 
correct identification scores (F(2,234) = 59.239, p = 0.002). Games-Howell post-hoc tests 
revealed that high (M = 4.46, SD = 2.09) and adequate (M = 4.52, SD = 2.13) functional 
health literacy respondents correctly identified significantly more paracetamol containing 
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pain medications than low (M = 3.21 SD = 2.14) functional health literacy respondents (p = 
.013; p = .002). 
Figure 2: Responses of 229 participant identifying paracetamol as an active ingredient in different 
prescription and OTC preparations. 
 
NB: Blue columns represent correct responses and red columns represent incorrect responses. X-axis labels are 
Trade Mark names. 
 
 
When asked how they knew which medicines contained paracetamol, of the 154 participants 
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packing; 42 (27.3%) indicated they guessed or didn’t know; 30 (19.5%) indicated they had 
experience with taking them in the past; 19 (12.3%) indicated they had asked a health 
professional (e.g. pharmacist/doctor/nurse) or were themselves a health professional; and 
only 4 (2.6%) indicated that they knew because of television advertising. It is also important 
to note that almost 40% of the participants (n = 100, 39.4%) did not respond to this question. 
Analysis of their behaviours, with regard to identifying which of the pharmaceutical products 
contain paracetamol as an active ingredient and their functional health literacy levels, found 
significant differences for guessing. That is, low functional health literacy score respondents 
were more likely to have guessed or didn’t know which products contained paracetamol (low 
functional health literacy scores n = 22, 55% versus adequate functional health literacy scores 
n = 12, 8.5% versus high functional health literacy scores n = 8, 14.6%; (2, N=42) = 
7.429, p = 0.024.  In contrast, respondents with high functional health literacy scores were 
significantly more likely to read the labels and/or packaging (high functional health literacy 
scores n =22, 40% versus adequate functional health literacy scores n = 26, 18.3% versus 
low functional health literacy scores n = 11, 27.5%; (2, N = 59) = 6.136, p = 0.047). High 
functional health literacy score respondents were also more likely to suggest that they knew 
based on their past experience with using the products (high functional health literacy scores 
n = 16, 29.1% versus adequate functional health literacy scores n = 13, 9.5% versus low 
functional health literacy scores  n  = 1, 2.5%; (2, N=30) = 12.60, p = 0.002).  
Discussion 
 
Self-management of medications is important for patients with chronic illness as it can assist 
in maintaining their quality of life and limit the frequency of visits to their healthcare 
practitioner. Both prescription and OTC medications play an important role in pain 
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management in many diseases, including various forms of arthritis. The population studied 
here, typical of the Australian profile of arthritis sufferers[1], was predominantly aged over 
55 and had been affected by arthritis for over 5 years. Their age alone would predispose the 
study participants to co-morbid conditions and the possibility of polypharmacy [21, 22]. This 
in turn would increase their chances of experiencing adverse drug events, especially if they 
were taking their pain medications inappropriately [17, 18, 23]. It is imperative that patients 
have good knowledge about the correct use of medications, an understanding about the active 
ingredients in different preparations, , and  an awareness of possible adverse effects 
associated with  taking several medications, including OTC medications, at the same time. 
Strategies which could be targeted to improve patient knowledge and understanding, and to 
reduce the risk of adverse drug events, include improved health care provider education about 
the active ingredient of both prescription and OTC pain medications[17] and improved 
patient-friendly labelling [17, 24]. In addition, pharmacists have an important role to play in 
pharmacovigilance of OTC pain medications [25], especially among their patients with low 
literacy. They also need to be cognisant that patients may have reasonable functional literacy 
in other areas but may exhibit low functional health literacy in terms of medication self-
management.  
In this study, most participants used prescription and/or OTC analgesic agents containing 
paracetamol to help manage their arthritic pain, especially Panadeine Forte™ (a combination 
of paracetamol 500mg and codeine 30mg) and Panadol Osteo™ (paracetamol 665mg). Even 
though the majority of respondents with adequate and high functional health literacy scores 
were able to correctly identify paracetamol as the active ingredient in many commonly 
available pharmaceutical products, it is important to note that respondents with low 
functional health literacy scores were significantly less likely to do so correctly. Moreover, 
respondents with low functional health literacy scores were also significantly more likely to 
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guess or simply didn’t know how to identify which products contained paracetamol as one of 
the active ingredients. This is of concern, especially for arthritic patients with low functional 
health literacy who are taking multiple medications containing paracetamol and putting 
themselves at risk of exceeding recommended daily doses of paracetamol. This potential 
harm is evidenced by the findings of a recent study [24], which reported that “potential for 
errors and adverse events associated with unintentional misuse of these products is 
substantial, particularly among…those with limited literacy” (p.1587). This situation may be 
further exacerbated in fasting patients, heavy users of alcohol and/or those taking 
concomitant medications which induce the cytochrome p450 system [26].   
 
The potential for the participants in the current study to experience adverse drug events and 
unintentional overdose could be further exacerbated by their inclination to borrow or share 
OTC pain medications. In contrast to reports in the literature suggesting that prescription pain 
medications are likely to be borrowed and shared [10, 11], a larger proportion of our study 
participants (almost 30%) responded that they had and/or intended to borrow/share their OTC 
pain medications, rather than their prescription pain medications (less than 10%). This is a 
worrying for all patients, and especially for those with low functional health literacy, who 
cannot correctly identify the active ingredients in many OTC pain preparations. Furthermore, 
as suggested by Ward et al [11], many of these patients are unlikely to have discussed this 
behaviour with their healthcare providers which is why it is important that all healthcare 
providers educate their patients about the potential harms associated with OTC pain 
medications, as well as prescription pain medications. 
In the current study, even though the majority of the study participants had adequate and high 
functional health literacy scores, the trade names of commonly available pharmaceutical 
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products may have influenced their perceptions of ingredients. For example, the majority of 
the respondents did not recognise that paracetamol was an active ingredient in combination 
pharmaceutical preparations, which did not contain the prefix ‘Pana’, such as Mersyndol™ 
(76.9%) and Chemists Own Cold & Flu Relief™ (58.1%). Furthermore, the majority of the 
respondents (56.8%) incorrectly identified Panafen Plus™ as a product containing 
paracetamol. Since our results indicate that participants with high functional health literacy 
scores were significantly more likely to read the labels and/or packaging or were more likely 
to recognise which products contained paracetamol because of past experience, it could be 
surmised that respondents with adequate and low functional health literacy scores made up 
the majority of the respondents who couldn’t correctly identify which of these combination 
products contained paracetamol. Unfortunately, this tendency for many patients to rely on the 
prefix ‘Pana’ to identify which products contain paracetamol could also lead to potential 
adverse drug events and/or toxicities. Using Panafen Plus™ as an example, if patients (who 
had contraindications for the concomitant use of NSAIDs[16, 18, 25] or were already taking 
multiple NSAIDs) bought or borrowed this OTC pain medication, believing it to contain 
paracetamol rather than a NSAID, they could be at risk of experiencing NSAID related 
adverse drug events and/or overdose. This is clearly an area requiring further study and 
highlights the need for all health professionals, and especially pharmacists, to ensure that all 
patients know where to find and how to interpret the active ingredients and the instructions 
for taking both prescription and OTC pain medications. 
Some limitations of this study need to be acknowledged. The sample population may not be 
representative of the entire population of people with arthritis, because participants with low 
functional health literacy skills, including those from CALD backgrounds may not have been 
able to complete or correctly understand the survey. It is also important to note that even 
18 
 
though the researchers tried to recruit Australia-wide participants, the majority of the 
participants were Illawarra-based residents.  
 
In conclusion, Australian people with arthritis, especially those with low functional health 
literacy, who are treating their pain with paracetamol-containing products may not always be 
able to recognise paracetamol to be an active ingredient in prescription and/or OTC 
pharmaceutical products, thereby inadvertently exposing themselves to potential paracetamol 
related adverse events and toxicity. Further investigations into this area of research are 
warranted.   
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